The proposed deadline for a second coronavirus disease 2019 (COVID-19) stimulus package has arrived; there is a new 3-digit number for mental health emergencies; several treatment options are available for patients who have COVID-19.
Based on the deadline set by House Speaker Nancy Pelosi, D-California, today is the last day for Democrats and Republicans to negotiate a second stimulus package to address the coronavirus disease 2019 pandemic (COVID-19). Reported by USA Today, both parties are noted to be hundreds of billions apart in their proposals and unable to resolve major policy differences on testing for SARS-CoV-2, the virus that causes COVID-19; child tax credit provisions; and funding for state and local governments. Pelosi told House Democrats in a letter on Sunday that she was optimistic a deal would be struck before the election, but some lawmakers have expressed their pessimism about its chances.
Reported by NPR, President Donald Trump signed into law a bipartisan bill to create a 3-digit number for mental health emergencies. The new hotline number, 988, picked by the Federal Communications Commission, could up and running by July 2022. The existing National Suicide Prevention Lifeline, 1-800-273-TALK, has seen a substantial rise in call volume in recent years for those seeking consultations, which mental health advocates say will become easier once the new, shorter number is in place. Experts are hoping the new number will lead to fewer dropped calls and shorter wait times.
With several experimental therapies being tested for efficacy and safety against COVID-19, an article by The Associated Press spotlights the current treatment options available for infected patients, courtesy of the National Institutes of Health. For example, for those hospitalized and needing extra oxygen but not a breathing machine, intravenous antiviral drug remdesivir is recommended, along with, in some cases, a steroid. Meanwhile, for patients hospitalized and on a breathing machine, remdesivir plus a steroid is advised. Convalescent plasma has yet to garner enough evidence to recommend for or against it, the report adds.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
2 Commerce Drive
Cranbury, NJ 08512